FDA 483 - Hemarus LLC - April 30, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Hemarus LLC, a Source Plasma Donor Center in Lauderhill, FL, revealed significant deficiencies across multiple areas of operation. The firm failed to adhere to standard operating procedures, maintain adequate records, ensure proper personnel training, and thoroughly investigate adverse events. Several critical issues, including inadequate donor privacy and adverse reaction investigations, were repeat observations from a previous inspection, indicating persistent compliance problems.
ID · 089af159-2304-4568-baa3-6fe2881b7a29